100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
You Searched
₹2,503.6
Our Recommendation
Soratib 200mg Tablet

244+ trust this
WHO GMP Certified


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Delivery by
In Liver cancer Liver cancer is the cancer that develops in the cells of the liver called hepatocytes. There may be no symptoms present in the early stages of the cancer but as the disease advances to later stages symptoms such as weight loss, stomach pain, vomiting and yellowed skin. Soranib Tablet kills the cancer cells and prevents further growth and spread of cancer to other unaffected areas. Follow your doctor?s instructions carefully and do not drink alcohol or smoke. Alcohol intake or smoking can worsen your condition and hinder your recovery. In Kidney cancer Soranib Tablet is used to treat kidney cancer and its associated symptoms such as blood in the urine, unexplained low back pain or weight loss, fatigue, loss of appetite, etc. It stops cancer growth and prevents multiplication of cancer cells. This restricts the advancement of cancer to other unaffected regions. You need to follow your doctor?s instructions very carefully to recover. In Thyroid cancer Thyroid is a butterfly-shaped gland located at the base of your neck. Your thyroid produces hormones that regulate your heart rate, blood pressure, body temperature and weight. Thyroid cancer occurs in the cells of the thyroid and it might not cause any symptoms at first. Soranib Tablet restricts the oxygen supply of the cancer cells and stops its growth as well as further spread. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Soranib Tablet is to be taken empty stomach.
Soranib Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Soranib Tablet . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Soranib Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Not Safe: Soranib Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
SAFE - Soranib Tablet does not usually affect your ability to drive.
Safe when prescribed by an expert: Soranib Tablet is safe to use in patients with kidney disease. No dose adjustment of Soranib Tablet is recommended. Regular monitoring of blood tests may be advised while you are taking this medicine.
Caution Advised: Soranib Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Soranib Tablet may be needed. Doctor consultation is advised.
If you forget a dose of Soranib Tablet , simply continue with your regular schedule and do not take a double dose.
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1740
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 955
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1274-75
Sorafenib. Emeryville, California: Onyx Pharmaceuticals, Inc.; 2005 (24 Jan. 2019)
Sorafenib tosilate. Reading, Berkshire: Bayer Plc.; 2006 (27 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (27 Mar. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.